Avid Bioservices Inc (CDMO)

[biopharm]

revenue monster, you have failed to prove your point and will give my reason further below:

To be fair couch. MSK and AZ have very little skin in the game. Still positive events however all being funded by pphm.

1) MSK = Memorial Sloan Kettering = #1 cancer hospital, so MSK DOES NOT bring PS Targeting into thousands of cancer patients at MSK for combination therapy without knowing how well it works and this tells me they certainly have skin in this game.

2) AZ R&D arm = Medimmune and with AZ announcing "partnership" with Peregrine tells me that is lots of skin in this game, especially since no other partnership was announced with the many other Medimmune collaborators like AZ has announced with Peregrine Pharmaceuticals.

3) "..all being funded by pphm " ? That is not a fact, because Peregrine and MSK / AZ all never disclosed any financial details so that tells me it is quite impossible to say " ..all being funded by pphm" because what is all ?? We know the partnership says Peregrine will conduct the "INITIAL TRIAL" but remember.... if there is an initial trial there are more, which is the "ALL" you refer to and pay close attention ==> no details were released so it is impossible to conclude that "ALL being funded by Peregrine"

Under the terms of the agreement, the initial trial will be conducted by Peregrine.

http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=928488